anayamalik, Author at European Medical Journal - Page 70 of 97

Anti-Inflammatory Drugs Linked to Lower Parkinson’s Risk

New research published highlights a potential link between anti-inflammatory treatments and a reduced risk of Parkinson’s disease (PD) in patients with autoimmune disorders.

Checkpoint Myocarditis: A Breakthrough in Immune Insights

Immune checkpoint inhibitors, widely used in cancer therapy, have revolutionized oncology but come with the risk of severe immune-related adverse events, including checkpoint myocarditis.

New COPD Screening Method Enhances Detection

Discover how a polygenic risk score enhances traditional methods for identifying undiagnosed COPD in at-risk populations, offering a significant step forward in diagnosis.

Sharp Surge in Pediatric Head Infections Since Pandemic

The incidence of serious head and neck infections (HNI) among children in the United States has surged dramatically since 2021, according to a new study.

Lifestyle Care Favored Over Guidelines for Back Pain

A recent randomized clinical trial has demonstrated that incorporating healthy lifestyle care into chronic low back pain management can provide small but meaningful improvements in disability, weight loss, and quality of life.

Breakthrough Trial Spotlights Skin Fragility of the Arms

A groundbreaking clinical trial has provided valuable insights into the management of dermatoporosis, a condition characterized by chronic extracellular matrix (ECM) degradation leading to skin atrophy and fragility.

Idiopathic Pulmonary Fibrosis Discovery Sparks Treatment Potential

Researchers at Vanderbilt University Medical Center, the University of Michigan Medical School, and the Translational Genomics Research Institute (TGen) have made significant strides in understanding idiopathic pulmonary fibrosis (IPF), an incurable and progressive lung disease.

White Button Mushrooms Found to Halt Cancer Progression

A groundbreaking study has revealed that white button mushrooms (WBM) may reduce immune suppression and enhance anti-cancer immune responses in patients with prostate cancer.

Interruptive Alerts Boost Suicide Risk Screening

A recent clinical trial sheds light on how interruptive clinical decision support (CDS) systems can significantly enhance suicide risk assessments in healthcare settings.

Study Reveals Pediatric Inflammatory Multisystem Syndrome Trends Over Pandemic

Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS), a severe inflammatory condition linked to COVID-19, has shown decreasing severity over successive pandemic waves, according to new data from Germany.